• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,802.90 -607.08
( -0.78%)
Global Indices
Nasdaq
51,585.70 72.15
(0.14%)
Dow Jones
7,521.58 80.48
(1.08%)
Hang Seng
70,971.12 -82.37
(-0.12%)
Nikkei 225
10,357.71 -41.99
(-0.40%)
Forex
USD-INR
94.39 -0.12
(-0.13%)
EUR-INR
108.40 -1.03
(-0.94%)
GBP-INR
125.08 -1.43
(-1.13%)
JPY-INR
0.59 0.00
(-0.50%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.6032787
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
36.55
70.23
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

Aarti Surfactants slumps after Q4 PAT tanks 57% YoY to Rs 4 cr
May 11,2026
Revenue from operations jumped 26.83% YoY to Rs 256.28 crore in the quarter ended 31 March 2026.

Total operating expenditure rose by 31.86% to Rs 250.59 crore in Q4 FY26 over Q4 FY25. Cost of Materials Consumed stood at Rs 186.40 crore (up 12.86%) and employee benefits expense (up 6.62% YoY).

Profit before tax for the March’26 quarter stood at Rs 5.88 crore, down 55.35% YoY from Rs 13.17 crore in March 2025.

On a full-year basis, the company’s consolidated net profit slipped 15.13% to Rs 12.34 crore on a 30.35% increase in total revenue from operations to Rs 859.13 crore in FY26 over FY25.

Aarti Surfactants is engaged in a product portfolio that includes surfactants, mild surfactants, rheology modifiers, pearlizing agents, UV filters, syndet and soap bases, and active ingredients, as well as conditioning agents, blends, proteins, and quats. It serves the skin care, oral, hair, cosmetics, bath and shower, sun care, fabric/laundry care, dishwashing, toilet care, and surface care segments.